Exome Asset Management LLC Liquidia Corp Transaction History
Exome Asset Management LLC
- $135 Billion
- Q2 2025
A detailed history of Exome Asset Management LLC transactions in Liquidia Corp stock. As of the latest transaction made, Exome Asset Management LLC holds 20,500 shares of LQDA stock, worth $556,575. This represents 0.19% of its overall portfolio holdings.
Number of Shares
20,500
Previous 20,500
-0.0%
Holding current value
$556,575
Previous $255 Million
-0.0%
% of portfolio
0.19%
Previous 0.19%
Shares
1 transactions
Others Institutions Holding LQDA
# of Institutions
219Shares Held
49.5MCall Options Held
1.61MPut Options Held
1.15M-
Black Rock Inc. New York, NY4.24MShares$115 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.24MShares$115 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$108 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY3MShares$81.5 Million18.2% of portfolio
-
Opaleye Management Inc. Boston, MA2.48MShares$67.2 Million7.37% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.75B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...